{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:58:40Z","timestamp":1790488720317,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/JRF-2010\/MPD- 45 (51910)"],"award-info":[{"award-number":["3\/1\/3\/JRF-2010\/MPD- 45 (51910)"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bcmd.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T03:46:26Z","timestamp":1432698386000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tyrosine kinase inhibitors: New class of antimalarials on the horizon?"],"prefix":"10.1016","volume":"55","author":[{"given":"Vrushali","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Colah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanjaksha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2015.05.007_bb0005","series-title":"World Malaria Report Factsheet (fs 094)","author":"WHO","year":"2014"},{"key":"10.1016\/j.bcmd.2015.05.007_bb0010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pt.2008.08.007","article-title":"Protein kinases of malaria parasites: an update","volume":"24","author":"Doerig","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0076-6879(05)07047-3","article-title":"Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF\/MEK\/ERK pathway in tumor cells and tyrosine kinases VEGFR\/PDGFR in tumor vasculature","volume":"407","author":"Adnane","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2015.05.007_bb0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0045","series-title":"Division of Control of Tropical Disease Review","article-title":"In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine\/pyrimetamine and artemisinin","volume":"2","author":"WHO","year":"2001"},{"key":"10.1016\/j.bcmd.2015.05.007_bb0050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4269\/ajtmh.2008.78.721","article-title":"In vitro activity of artemisinin in combination with clotrimazole or heat-treated amphotericin B against Plasmodium falciparum","volume":"78","author":"Bhattacharya","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0055","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0060","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0020-7519(97)00080-5","article-title":"Continuous culture of Plasmodium falciparum: its impact on malaria research","volume":"27","author":"Trager","year":"1997","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ncomms1558","article-title":"Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum","volume":"2","author":"Solyakov","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2164-5-79","article-title":"Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote","volume":"5","author":"Ward","year":"2004","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bcmd.2015.05.007_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nchembio.87","article-title":"Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility","volume":"4","author":"Kato","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0080","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1046\/j.1432-1327.2001.02403.x","article-title":"The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes","volume":"268","author":"Syin","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1083\/jcb.200505117","article-title":"Cyclic AMP and calcium interplay as second messengers in melatonin-dependent regulation of Plasmodium falciparum cell cycle","volume":"170","author":"Beraldo","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0090","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1590\/S0100-879X2003001100003","article-title":"Interruption of the blood-stage cycle of the malaria parasite, Plasmodium chabaudi, by protein tyrosine kinase inhibitors","volume":"36","author":"Gazarini","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1098\/rstb.1999.0426","article-title":"Antimalarial drug resistance and combination chemotherapy","volume":"354","author":"White","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Tracking Resistance to Artemisinin Collaboration (TRAC). Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0105","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","article-title":"Assessment of the pharmacodynamic properties of antimalarial drugs in vivo","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcmd.2015.05.007_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ctrv.2010.10.001","article-title":"Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?","volume":"37","author":"VonMehren","year":"2011","journal-title":"Cancer Treat. Rev."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:30:55Z","timestamp":1761049855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979615000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1079979615000959"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.007","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine kinase inhibitors: New class of antimalarials on the horizon?","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}